Table 1.

Correlation of HN1L expression with clinicopathological features in NSCLC patients.

		HN1L expression
Clinical features	Cases	Normal (n = 51)	Upregulated (n = 58)	P value
Gender				0.450
Male	90	44 (48.9%)	46 (51.1%)
Female	19	7 (36.8%)	12 (63.2%)
Age (years old)				0.833
≤65	77	37 (48.1%)	40 (51.9%)
>65	32	14 (43.7%)	18 (56.3%)
Smoking				1.000
Smokers	29	14 (48.3%)	15 (51.7%)
Never smokers	80	37 (46.2%)	43 (53.8%)
Histological subtype				0.661
SCC	79	31 (39.2%)	48 (60.8%)
ADC	30	10 (33.3%)	20 (66.7%)
Differentiated degree				1.000
I+II	77	36 (46.8%)	41 (53.2%)
III	32	15 (46.9%)	17 (53.1%)
Adjacent organs invasion				0.830
Negative	30	15 (50.0%)	15 (50.0%)
Positive	79	36 (45.6%)	43 (54.4%)
Tumor size (cm)				0.022
≤4	47	28 (59.6%)	19 (40.4%)
>4	62	23 (37.1%)	39 (62.9%)
Lymph node metastasis				0.567
Negative	55	24 (43.6%)	31 (56.4%)
Positive	54	27 (50.0%)	27 (50.0%)
Clinical stage				1.000
I+II	70	33 (47.1%)	37 (52.9%)
III+IV	39	18 (46.2%)	21 (53.8%)	□

SCC, squamous carcinoma; ADC, adenocarcinoma. Statistical significance (P < 0.05) is shown in bold.